当前位置:首页 - 行情中心 - 灵康药业(603669) - 财务分析 - 现金流量表

灵康药业

(603669)

  

流通市值:36.57亿  总市值:36.57亿
流通股本:7.21亿   总股本:7.21亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金256,887,980.39176,565,565.6937,359,969.68235,291,466.02
  收到其他与经营活动有关的现金21,602,442.419,825,375.06526,291.9847,237,607
  经营活动现金流入小计278,490,422.79196,390,940.7537,886,261.66282,529,073.02
  购买商品、接受劳务支付的现金200,079,495.71117,119,438.7813,243,955.39208,548,318.97
  支付给职工以及为职工支付的现金35,762,503.9227,541,748.615,935,507.2647,790,751.15
  支付的各项税费13,202,906.9412,307,224.8810,074,437.217,917,388.89
  支付其他与经营活动有关的现金147,498,149.1378,382,437.3912,202,323.4129,161,372.4
  经营活动现金流出小计396,543,055.7235,350,849.6551,456,223.26393,417,831.41
  经营活动产生的现金流量净额-118,052,632.91-38,959,908.9-13,569,961.6-110,888,758.39
二、投资活动产生的现金流量:
  收回投资收到的现金9,689,834.219,689,834.21--
  取得投资收益收到的现金1,114,006.211,114,006.218,501.178,098,888.52
  处置固定资产、无形资产和其他长期资产收回的现金净额9,457,504.85191,000152,0002,067,600
  收到的其他与投资活动有关的现金17,332,76217,332,76217,332,762367,000,000
  投资活动现金流入小计37,594,107.2728,327,602.4217,493,263.17377,166,488.52
  购建固定资产、无形资产和其他长期资产支付的现金1,024,744.02825,650.02543,497.568,847,836.79
  支付其他与投资活动有关的现金---2,532,762
  投资活动现金流出小计1,024,744.02825,650.02543,497.5611,380,598.79
  投资活动产生的现金流量净额36,569,363.2527,501,952.416,949,765.61365,785,889.73
三、筹资活动产生的现金流量:
  取得借款收到的现金5,000,000---
  收到其他与筹资活动有关的现金252,008,404.39252,008,404.392,008,404.39220,036,467.43
  筹资活动现金流入小计257,008,404.39252,008,404.392,008,404.39220,036,467.43
  偿还债务支付的现金1,008.251,008.25-322,178,500
  分配股利、利润或偿付利息支付的现金---5,729,920.06
  支付其他与筹资活动有关的现金250,000,000250,000,000-214,206,515.01
  筹资活动现金流出平衡项目00-0
  筹资活动现金流出小计250,001,008.25250,001,008.25-542,114,935.07
  筹资活动产生的现金流量净额7,007,396.142,007,396.142,008,404.39-322,078,467.64
五、现金及现金等价物净增加额-74,475,873.52-9,450,560.365,388,208.4-67,181,336.3
  加:期初现金及现金等价物余额247,269,420.52247,269,420.52247,269,420.52314,450,756.82
  期末现金及现金等价物余额172,793,547237,818,860.16252,657,628.92247,269,420.52
补充资料:
  净利润--35,733,685.77--130,763,688.85
  资产减值准备-107,822.6-32,296,796.18
  固定资产和投资性房地产折旧-11,781,614.91-26,714,779.22
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-11,781,614.91-26,714,779.22
  无形资产摊销-3,438,427.45-7,287,065.72
  长期待摊费用摊销-1,443,838.73-3,474,385.14
  处置固定资产、无形资产和其他长期资产的损失-49,322.73--83,625.67
  固定资产报废损失-206,027.62-93,928.87
  公允价值变动损失-347,222.93-1,862,431.19
  财务费用-10,272,529.67--4,925,154.54
  投资损失-3,046,508.71-12,723,355.72
  递延所得税--232,533.66-1,563,557.75
  其中:递延所得税资产减少---2,198,900.92
    递延所得税负债增加--232,533.66--635,343.17
  存货的减少--21,021,707.83-26,262,210.64
  经营性应收项目的减少-1,751,629.05--201,431,637.27
  经营性应付项目的增加--19,273,933.27-92,927,368.23
  其他--70,978.48--
  现金的期末余额-237,818,860.16-247,269,420.52
  减:现金的期初余额-247,269,420.52-314,450,756.82
  现金及现金等价物的净增加额--9,450,560.36--67,181,336.3
公告日期2025-10-312025-08-232025-04-262025-04-19
审计意见(境内)标准无保留意见
TOP↑